HIGHLIGHTS
- who: August and collaborators from the Chinese Academy of Medical Sciences China Nanjing Medical, China have published the Article: Cardiotoxicity associated with immune checkpoint inhibitors: Current status and future challenges, in the Journal: (JOURNAL)
- what: The aim of this review is to summarize the latest epidemiological evidence of cardiovascular toxic effects of PD-1/ PDL-1 inhibitors as well as the clinical presentation and possible underlying mechanisms, to provide new strategies for clinical prevention and treatment and to minimize the incidence of fatal cardiac events associated with ICI treatments. Myocarditis Pathological mechanism of ICIrelated cardiotoxicity . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.